Sorrento TherapeuticsSRNE
13F holders, Q4 2024 (December 31)5holders +1
1new positions
1sold out
$0.00avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Sorrento Therapeutics Inc. (SRNE) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were Kingswood Wealth Advisors, LLC ($32), Lattice Capital Management, LLC ($26) and Huntington National Bank ($4).
- Company
- Sorrento Therapeutics Inc.
- CUSIP
- 83587F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32 |
| Exits | 1 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 65,650 shares bought and 21,433 shares sold, net +44,217 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Kingswood Wealth Advisors, LLC | 0.00% | New | 65,650 | $32 |
| Lattice Capital Management, LLC | 0.00% | No change | 51,800 | $26 |
| Huntington National Bank | 0.00% | No change | 5,001 | $4 |
| HighPoint Advisor Group LLC | 0.00% | No change | 22,250 | $4 |
| Flagship Wealth Advisors, LLC | 0.00% | — | 500 | $0 |
"% of holder's portfolio" is SRNE's weight in each manager's 13F, not the share of Sorrento Therapeutics Inc. the manager owns.